The purchase price for the assets is approximately $15.2 million in stock and cash. Alphatec Spine said that it expects this transaction to contribute approximately $15 million in revenue in 2013. Additional details regarding the transaction will be provided if and when the acquisition is closed.
More Articles on Orthopedic Devices:
Smith Nephew Updates Indications for Birmingham Hip Implants
Biomet Announces Lifetime Warranty on Oxford Partial Knee
EOS imaging Announces First Installation in Asia
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.